ITGA5 and infarction: Echocardiographic analysis showed that myeloid cell-specific ITGA5 deletion accentuated adverse remodeling after infarction, increasing LVEDV (Fig. 2D) and LVESV (Fig. 2E), 28 days after coronary occlusion.